A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with alzheimer disease

Joel E. Streitn, Anton P. Porsteinsson, Christopher D. Breder, Rene Swanink, Ronald Marcus, Robert McQuade, William H. Carson

Research output: Contribution to journal › Article › peer-review